Logo for IceCure Medical Ltd

IceCure Medical Investor Relations Material

Latest events

Logo for IceCure Medical Ltd

Q1 2024

IceCure Medical
Logo for IceCure Medical

Q1 2024

28 May, 2024
Logo for IceCure Medical

Q4 2023

3 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from IceCure Medical Ltd

Access all reports
IceCure Medical Ltd. is a commercial-stage medical device company that focuses on the development and marketing of cryoablation systems. Utilizing liquid nitrogen-based technology, the company offers minimally invasive treatments for both benign and malignant tumors, primarily targeting applications in women's health and interventional oncology. IceCure Medical's flagship product, the ProSense Cryoablation System, destroys tumors by freezing them, providing an alternative to traditional surgical tumor removal. IceCure Medical Ltd. is headquartered in Caesarea, Israel, and its shares are listed on the NASDAQ.